Author

Reina Umeno

Observed names: R Umeno, UMENO, Reina, Umeno, Reina

Observed institutions: Kawasaki Medical School, University of Oxford, MRC Population Health Research Unit

OpenAlex ID: A5023816005

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

2023 · PK Judge, N Staplin, et al. · The Lancet Diabetes & Endocrinology · 123

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

2023 · N Staplin, R Haynes, et al. · The Lancet Diabetes & Endocrinology · 100

Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis

2023 · Hiroyuki Kadoya, Akira Hirano, et al. · The FASEB Journal · 13

Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases

2026 · Brendon L. Neuen, Vlado Perkovic, et al. · JAMA · 9

Insights into the Regulation of GFR by the Keap1-Nrf2 Pathway

2023 · Kengo Kidokoro, Hiroyuki Kadoya, et al. · Kidney360 · 9

Endothelial Dysfunction Accelerates Impairment of Mitochondrial Function in Ageing Kidneys via Inflammasome Activation

2021 · Yoshihisa Wada, Reina Umeno, et al. · International Journal of Molecular Sciences · 8

ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice

2024 · Eriko Kajimoto, Hajime Nagasu, et al. · Scientific Reports · 7

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis

2026 · Hiddo J L. Heerspink, Jelle M Beernink, et al. · European Heart Journal

The deficient of eNOS-NO pathway exacerbates kidney dysfunction via inflammasome activation in diabetic kidney disease

2023 · UMENO, Reina, NAGASU, Hajime, et al. · Institutional Repositories DataBase (IRDB)

The eNOS-NO Pathway Attenuates the Progression of Age-Related Kidney Diseases via Suppression of C/EBPβ-Associated Inflammaging

2021 · Reina Umeno, Hajime Nagasu, et al. · Journal of the American Society of Nephrology

Elucidation of Glomerular Hemodynamic Changes by SGLT-2 Inhibitors and ARBs in a Type 2 Diabetic Animal Model Using In Vivo Imaging

2021 · Yoshihisa Wada, Kengo Kidokoro, et al. · Journal of the American Society of Nephrology

The lack of eNOS-NO pathway exacerbates kidney dysfunction via inflammasome activation in diabetic kidney diseases mice model

· 梅野, 怜奈, Umeno, Reina · Institutional Repositories DataBase (IRDB)

Dipeptidyl peptidase-4 inhibitor linagliptin reduces urinary albumin excretion through the protection of glomerular endothelial function

· KONDO, Megumi, KIDOKORO, Kengo, et al. · Institutional Repositories DataBase (IRDB)

Works count: 12

Citation count: 269

H-index: 7

I10-index: 3